Who is the manufacturer of Delphi MCS Electrode Cap?

Quantalx Neuroscience, Ltd. filed the 510(k) submission for Delphi MCS Electrode Cap (K243243).

What is the FDA product code for Delphi MCS Electrode Cap?

GXY. It is classified under 21 CFR 882.1320 as a Class 2 device in the Neurology panel.

What is the regulatory pathway for Delphi MCS Electrode Cap?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like Delphi MCS Electrode Cap?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Delphi MCS Electrode Cap

K243243 · Quantalx Neuroscience, Ltd. · GXY · Feb 6, 2025 · Neurology

Device Facts

Record ID	K243243
Device Name	Delphi MCS Electrode Cap
Applicant	Quantalx Neuroscience, Ltd.
Product Code	GXY · Neurology
Decision Date	Feb 6, 2025
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 882.1320
Device Class	Class 2

Intended Use

Delphi MCS Electrode Cap is an EEG electrode set intended for routine clinical settings where rapid placement of large number of EEG electrodes is desired.

Device Story

Delphi MCS Electrode Cap is an EEG electrode set consisting of an elastic textile cap with integrated Ag/AgCl sintered electrodes; designed for rapid, standardized electrode placement on the scalp using the International 10-20 system. The device is used in clinical settings by neurologists or trained technicians to record electrophysiological signals. The cap is secured via a chinstrap; conductive hydrogel is applied to the electrode base to facilitate signal transmission to external data collection devices. The device does not perform stimulation or transmit electrical current. By providing consistent electrode positioning and reducing setup time, the cap facilitates efficient EEG data acquisition, aiding clinicians in diagnostic assessments. The device is reusable and compatible with standard EEG amplifiers.

Clinical Evidence

No clinical data. The device underwent extensive non-clinical bench testing, including biocompatibility (ISO 10993-5, -10, -23), electrical safety (IEC 60601-1), and performance testing (use cycle reliability, impedance, offset voltage, bias current tolerance, and shelf life).

Technological Characteristics

Elastic textile (neoprene) cap with polyurethane electrode mounts. Features Ag/AgCl sintered electrodes. Connectivity via D-sub, KEL, or Touchproof DIN connectors. Impedance max 5 kΩ. Non-sterile. Reusable. Follows International 10-20 system. Sizes M to XL.

Indications for Use

Indicated for adults and teenagers in routine clinical settings requiring rapid placement of multiple EEG electrodes for electrophysiological signal recording.

Regulatory Classification

Identification

A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.

Predicate Devices

Electro-Cap System (K112319)

Related Devices

K211315 — Comby EEG Caps · Pamel D.O.O · Nov 9, 2021
K071446 — ELECTRODE ARRAY CAP · Electrode Arrays · Jul 2, 2008
K240575 — WaveGuard Net EEG Cap (NA-245, NA-255, NA-261, NA-265, NA-271, NA-281) · Eemagine Medical Imaging Solutions GmbH · Nov 25, 2024
K112319 — ELECTRO-CAP SYSTEM · Electro-Cap Intl., Inc. · Jan 27, 2012
K254033 — Ceribell Instant EEG Headset · Ceribell, Inc. · Feb 9, 2026

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The FDA text logo is in blue and includes the words "FDA U.S. FOOD & DRUG" on the top line and "ADMINISTRATION" on the bottom line. February 6, 2025 QuantalX Neuroscience, Ltd. % Bosmat Friedman-Cox Regulatory Consultant ProMedoss, Inc 6026 Beech Cove Ln. Charlotte, North Carolina 28269 Re: K243243 Trade/Device Name: Delphi MCS Electrode Cap Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Regulatory Class: Class II Product Code: GXY Dated: October 11, 2024 Received: January 17, 2025 Dear Bosmat Friedman-Cox: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory {2}------------------------------------------------ assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, # Tushar Bansal -S for Heather Dean, PhD Assistant Director, Acute Injury Devices Team DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## Indications for Use Submission Number (if known) K243243 Device Name Delphi MCS Electrode Cap Indications for Use (Describe) Delphi MCS Electrode Cap is an EEG electrode set intended for routine clinical settings where rapid placement of large number of EEG electrodes is desired. Type of Use (Select one or both, as applicable) > | Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) ## CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ # 510(k) Summary K243243 Date Prepared: January 17, 2025 #### 1 SUBMITTER ## Applicant's Name: QuantalX Neuroscience 1 Hatachana St. Kfar-Saba Israel ## Primary Contact: Bosmat Friedman Regulatory Affairs Consultant 6026 Beech Cove Ln. Charlotte, NC 28269 Phone: 980-308-1636 bosmat.f(@promedoss.com ## Device: Trade/Device Name: Delphi MCS Electrode Cap Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Regulatory Class: Class II Product Code: GXY #### 2 PREDICATE DEVICE ## Primary Predicate: Manufacturer: Electro-Cap International Inc Trade name: Electro-Cap System Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Product code: GXY 510(k) number: K112319 #### 3 DEVICE DESCRIPTION The Delphi MCS Electrode Cap is made of elastic textile material, preserving the shape and size. The cap provides the exact position of the electrodes on the head without the need for additional measurements and adjustments. Large holes are provided for ventilation and access to the electrodes and patient's skin. The cap is fixed to the head with a chinstrap. The Cap is available in the following sizes: XL 60-66cm, XL/L 57-63cm, L 54-60cm, L/M 51-57cm, M 48-54cm. The textile caps sizes are identifiable by the color material or seam and marking according to international system 10-20. The Ag/AgCl electrodes are designed to provide minimal polarization and long-term stability of the signal. {5}------------------------------------------------ The conductive surface of the electrodes which is housed inside the electrode base does not have direct skin contact; an electrically conductive substance (hydrogel) is used inside the electrode base for improved conductivity. Delphi Cap electrodes are thin cup Ag/AgCl sintered electrode for EEG recording. The electrodes are designed for maximum comfort while the patient in a supine position. The design of this electrode is suitable for conducting combined TMS-EEG studies. The Ag/AgCl sintered electrode material guarantees minimum polarization and long-term signal stability, as well as an increased electrode life. #### 4 INDICATIONS FOR USE Delphi MCS Electrode Cap is an EEG electrode set intended for routine clinical settings where rapid placement of large number of EEG electrodes is desired. ## 5 SUBSTANTIAL EQUIVALENCE The Delphi MCS Electrode Cap is substantially equivalent to the predicate device based on the following: ## 5.1 Intended Use The intended use of the proposed device is the same as that of the cleared device. ## 5.2 Technology The Delphi MCS Electrode Cap has similar overall technological characteristics as the predicate Electro-Cap System (K112319). Both devices are comprised of an elastic fabric cap which allows for the connection of multiple electrodes via plastic electrode mounts incorporated in the cap. In both devices, electrode placement follows International 10-20 System of Electrode Placement. Both devices include Ag/AgCl electrode sensors and transmit electrophysiological signals from the patient to data collection devices with maximum impedance of 5 kΩ. The Delphi MCS Electrode Cap is available in the following sizes: XL (60-66cm), XL/L (57-63cm), L(54-60cm), L/M (51-57cm), and M color coded per international standards. The cap is provided with electrodes, connectors, ear clips and a chinstrap. | Attribute | Subject Device Delphi MCS Electrode Cap | Predicate Device Electro-Cap System | Comparison | |------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------| | 510(k) Number | TBD | K112319 | -- | | Classification | GXY | GXY | Same | | Regulation Number | 882.132 | 882.132 | Same | | Indications for use | Delphi MCS Electrode Cap is an EEG electrode set intended for routine clinical settings where rapid placement of large number of EEG electrodes is desired. | The Electro-Cap System is intended for use in routine clinical and research settings where rapid placement of a number of EEG electrodes is desired. | Same | | | Subject Device | Predicate Device | Comparison | | Attribute | Delphi MCS Electrode Cap | Electro-Cap System | | | Target population | Adults | Adults, children, newborns, babies (infants) | Subject device includes only sizes relevant to adults and teenagers; equivalent | | Intended user | Trained Technician, Neurologist | Trained Technician, Neurologist | Same as predicate | | Environment of use | Electrophysiological | Electrophysiological | Same as predicate | | Patient position | Sitting or reclining or supine position | Sitting or reclining or supine position | Same as predicate | | Contact duration | Short-term | Short-term | Same as predicate | | Number of electrodes (excluding ear electrodes) | Up to 32 | Up to 256 | Subject device has less electrodes but is within the range of the predicate; equivalent | | EEG leads Scheme | 10-20 | 10-20, 10-10, 10-5 | Substantially Equivalent | | Size of caps | Various sizes available (M to XL) | Various sizes available (babies to adult sizes) | Similar; subject device caps fall within the range of predicate sizes | | Style of Caps | Full Head Cap with chinstrap or chest belt, ear slits | Full Head Cap with chinstrap or chest-belt, ear slits | Same as predicate | | Cap material | Textile material (neoprene) | Textile material (spandex) | Similar; both devices underwent biocompatibility tests | | Electrode mounts | Plastic (polyurethane) | Plastic (polyethylene) | Similar; both devices underwent biocompatibility tests | | Location of wiring | Outside cap | Inside cap | Different; wire location does not introduce new safety or effectiveness concerns | | Cable length | Various - 1.2 m to 1.8 m | Various – 0.9 m to 1.5 m (3 to 5 feet) | Similar; length difference does not introduce new safety or effectiveness concerns | | Type of cable | Standard ribbon cable or/and lead wires or/and shielded lead wires | Standard ribbon cable or/and lead wires or/and shielded lead wires | Same | | Type of electrode drop | Detachable | Detachable and non-detachable | Substantially Equivalent | | Electrode sensor material | Ag/AgCl | Pure Tin, Ag, Ag/AgCl, Gold | Similar to predicate; both devices underwent biocompatibility tests | | Type of connectors | D-sub connectors, KEL connector, Touchproof Din sockets and special connectors to match EEG equipment | D-sub connectors, Touchproof Din sockets and special connectors to match EEG equipment | Same | | Method of connection to amplifier | Directly (if scheme is compatible) or through a special cable/adapter | Directly (if scheme is compatible) or through a special cable/adapter | Same | | Performance requirements | Needs to transmit electrophysiological signals from an individual to data collection devices | Needs to transmit electrophysiological signals from an individual to data | Similar to predicate | | Attribute | Subject Device | Predicate Device | Comparison | | | Delphi MCS Electrode Cap | Electro-Cap System | | | with maximum impedance of 5 kΩ and parameters. Does not transmit electrical current, nor are they intended to be used for stimulation | collection devices with maximum impedance of 5 kΩ and parameters. Does not transmit electrical current, nor are they intended to be used for stimulation | | | | Reusability | Reusable | Reusable | Same | | Conductive gel | Use only with FDA cleared gel | Use only with FDA cleared gel | Same | | Sterile | No | No | Same | {6}------------------------------------------------ {7}------------------------------------------------ ## 6 DISCUSSION Based on the comparison presented in our submission, the Delphi MCS Electrode Cap shares the same indications for use as its predicate, as both are intended for rapid placement of a large number of EEG electrodes. Additionally, while some technological differences do exist between the subject device and its predicate, testing have demonstrated that the device is substantially equivalent to its predicate and that the technological differences do not raise new safety and effectiveness concerns and support the company's substantial equivalency claim. ## 7 PERFORMANCE DATA The Delphi MCS Electrode Cap underwent successful nonclinical bench tests to establish substantially equivalent performance. Performance tests included: - Biocompatibility: - o Cytotoxicity per ISO 10993-5:2009 - Sensitization per ISO 10993-10:2021 o - o Irritation per ISO 10993-23:2021 - Electrical safety per IEC 60601-1 - - Use cycle reliability and durability testing (resistance, noise, impedance, durability and repeated cleaning cycles) - -AC Impedance - Offset Voltage - - Combined offset instability and internal noise - - Bias current tolerance - - Shelf Life - - -Conductive connection compliance The biocompatibility evaluation was conducted within the risk management framework and in compliance with ISO 10993 standards. This evaluation of the device included relevant data sources related to biological safety of finished device testing, and component material history of safe biological use and testing. This biocompatibility evaluation establishes the biological safety for the Delphi MCS Electrode Cap. The results of the performance bench testing support the safety profile of the device and demonstrate that the device functions as intended. {8}------------------------------------------------ #### CONCLUSION 8 The Delphi CMS Electrode Cap has similar intended use, technological characteristics, and principles of operation as the predicate. Any differences between the subject and predicate device were evaluated through design verification and validation testing which demonstrated device performance and safety, and do not raise any new questions of safety and effectiveness. Based on the information submitted in this 510(k), the Delphi MCS Electrode Cap is substantially equivalent to the predicate Electro-Cap System.